First-line high-dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas—a single-centre experience in 61 patients

Primary central nervous system non-Hodgkin lymphomas (PCNS-NHLs) are extranodal B-cell lymphomas with poor prognosis. The role of high-dose therapy (HDT) followed by autologous blood stem cell transplantation (ASCT) as first-line therapy is still not clear. We retrospectively collected long-term fol...

Descripción completa

Detalles Bibliográficos
Autores principales: Brezina, T., von Dewitz, H., Schroeder, T., Ullrich, S., Nachtkamp, K., Reifenberger, G., Malzkorn, B., Sabel, M., Haas, R., Kobbe, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810459/
https://www.ncbi.nlm.nih.gov/pubmed/34982196
http://dx.doi.org/10.1007/s00277-021-04745-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810459/
https://www.ncbi.nlm.nih.gov/pubmed/34982196
http://dx.doi.org/10.1007/s00277-021-04745-z

Ejemplares similares